Association of Expression Patterns of ER, PR, HER-2/neu and Ki67 with Nottingham Tumor Grade in Breast Cancer Biopsies
ER, PR, HER2 and Ki-67 in Relation to Nottingham Tumor Grade in Breast Cancer
DOI:
https://doi.org/10.55279/jafmdc.v8i1.634Keywords:
Breast cancer, Estrogen receptor, HER-2/neu, Immunohistochemistry, Ki-67, Nottingham grade, Progesterone receptorAbstract
Objective: To examine the association of expression patterns of ER, PR, HER-2/neu, and Ki-67 with Nottingham tumor grade in breast cancer biopsies. Methodology: This was a cross-sectional study, which included 876 histologically confirmed breast carcinoma cases at Meezan Lab, Faisalabad, from January 2020 to December 2024. The Nottingham (modified Scarff-Bloom-Richardson) grading system was used to grade tumors. ER, PR, HER-2/neu, and Ki-67 were all subjected to immunohistochemistry. Pearson correlation and chi-square tests were performed, with p-values <0.05 considered statistically significant.
Results: The majority of patients were in the 40–50-year age range. The most frequent histological subtype was invasive ductal carcinoma (91.2%), and the most common tumors were Grade II (50.7%), followed by Grade III tumors (48.7%). The positivity rates of ER and PR were 50.9% and 35.5%, respectively, while that of HER-2/neu was 51.6%. A high Ki-67 proliferation index was mostly found in higher-grade (grade III) tumors. Nottingham grade had a significant positive association with ER (p<0.001), PR (p<0.001), HER-2/neu (p=0.013), and Ki-67 (p<0.001). Ki-67 had the strongest association with tumor grade.
KEYWORDS: Breast cancer; Estrogen receptor; HER-2/neu; Immunohistochemistry; Ki-67; Nottingham grade; Progesterone receptor
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 shireem Hamid, Dr. Muhammad Mudassar, Dr. Usama Rehman , Dr. Iqra Khalid, Dr. Sadia Hameed , Dr. Tariq Mehmood

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
Non Commercial — You may not use the material for commercial purposes.
-
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.










